Xingui Liu

ORCID：0000-0003-2659-8007

发表论文 52 篇 · 总被引 2710 次 · h-index 18

代表论文

• Using proteolysis-targeting chimera technology to reduce navitoclax platelet toxicity and improve its senolytic activity (2020 · Nature Communications · 被引 270)
• Proximity-Based Modalities for Biology and Medicine (2023 · ACS Central Science · 被引 194)
• Discovery of XL01126: A Potent, Fast, Cooperative, Selective, Orally Bioavailable, and Blood–Brain Barrier Penetrant PROTAC Degrader of Leucine-Rich Repeat Kinase 2 (2022 · Journal of the American Chemical Society · 被引 177)
• Development of a BCL-xL and BCL-2 dual degrader with improved anti-leukemic activity, (2021 · Nature Communications · 被引 153)
• Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies (2020 · Journal of Hematology & Oncology · 被引 125)
• Piperlongumine conjugates induce targeted protein degradation (2023 · Cell chemical biology · 被引 71)